Effect of efavirenz-based ART on the pharmacokinetics of rifampicin and its primary metabolite in patients coinfected with TB and HIV.
J Antimicrob Chemother. 2021 Oct 11;76(11):2950-2957. doi: 10.1093/jac/dkab258.
J Antimicrob Chemother. 2021.
PMID: 34337654
Free PMC article.